These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25996606)

  • 1. Recommended mass spectrometry-based strategies to identify botulinum neurotoxin-containing samples.
    Kalb SR; Baudys J; Wang D; Barr JR
    Toxins (Basel); 2015 May; 7(5):1765-78. PubMed ID: 25996606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS.
    Kalb SR; Garcia-Rodriguez C; Lou J; Baudys J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR
    PLoS One; 2010 Aug; 5(8):e12237. PubMed ID: 20808925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Botulinum Toxins A, B, E, and F in Foods by Endopep-MS.
    Kalb SR; Krilich JC; Dykes JK; Lúquez C; Maslanka SE; Barr JR
    J Agric Food Chem; 2015 Feb; 63(4):1133-1141. PubMed ID: 25578960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative and Quantitative Detection of Botulinum Neurotoxins from Complex Matrices: Results of the First International Proficiency Test.
    Worbs S; Fiebig U; Zeleny R; Schimmel H; Rummel A; Luginbühl W; Dorner BG
    Toxins (Basel); 2015 Nov; 7(12):4935-66. PubMed ID: 26703724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples.
    Kalb SR; Moura H; Boyer AE; McWilliams LG; Pirkle JL; Barr JR
    Anal Biochem; 2006 Apr; 351(1):84-92. PubMed ID: 16500606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay.
    Wang D; Krilich J; Baudys J; Barr JR; Kalb SR
    Anal Biochem; 2015 Jan; 468():15-21. PubMed ID: 25232998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification and validation of the Endopep-mass spectrometry method for botulinum neurotoxin detection in liver samples with application to samples collected during animal botulism outbreaks.
    Tevell Åberg A; Karlsson I; Hedeland M
    Anal Bioanal Chem; 2021 Jan; 413(2):345-354. PubMed ID: 33119784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced detection of type C botulinum neurotoxin by the Endopep-MS assay through optimization of peptide substrates.
    Wang D; Krilich J; Baudys J; Barr JR; Kalb SR
    Bioorg Med Chem; 2015 Jul; 23(13):3667-73. PubMed ID: 25913863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive detection of type G botulinum neurotoxin through Endopep-MS peptide substrate optimization.
    Wang D; Baudys J; Hoyt K; Barr JR; Kalb SR
    Anal Bioanal Chem; 2019 Aug; 411(21):5489-5497. PubMed ID: 31172236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommended Immunological Strategies to Screen for Botulinum Neurotoxin-Containing Samples.
    Simon S; Fiebig U; Liu Y; Tierney R; Dano J; Worbs S; Endermann T; Nevers MC; Volland H; Sesardic D; Dorner MB
    Toxins (Basel); 2015 Nov; 7(12):5011-34. PubMed ID: 26703727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum Neurotoxins: Qualitative and Quantitative Analysis Using the Mouse Phrenic Nerve Hemidiaphragm Assay (MPN).
    Bigalke H; Rummel A
    Toxins (Basel); 2015 Nov; 7(12):4895-905. PubMed ID: 26610569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of botulinum neurotoxin serotypes A and B from serum using mass spectrometry.
    Parks BA; Shearer JD; Baudys J; Kalb SR; Sanford DC; Pirkle JL; Barr JR
    Anal Chem; 2011 Dec; 83(23):9047-53. PubMed ID: 22017298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and Characterization of Six Recombinant Botulinum Neurotoxins as Reference Material to Serve in an International Proficiency Test.
    Weisemann J; Krez N; Fiebig U; Worbs S; Skiba M; Endermann T; Dorner MB; Bergström T; Muñoz A; Zegers I; Müller C; Jenkinson SP; Avondet MA; Delbrassinne L; Denayer S; Zeleny R; Schimmel H; Åstot C; Dorner BG; Rummel A
    Toxins (Basel); 2015 Nov; 7(12):5035-54. PubMed ID: 26703728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on botulinum neurotoxins type /C1 and mosaic/DC using Endopep-MS and proteomics.
    Moura H; Terilli RR; Woolfitt AR; Gallegos-Candela M; McWilliams LG; Solano MI; Pirkle JL; Barr JR
    FEMS Immunol Med Microbiol; 2011 Apr; 61(3):288-300. PubMed ID: 21205003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a clinical assay for botulinum neurotoxins through mass spectrometric detection.
    Hoyt KM; Barr JR; Hopkins AO; Dykes JK; Lúquez C; Kalb SR
    J Clin Microbiol; 2024 Jun; 62(6):e0162923. PubMed ID: 38687021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Characterization of Monoclonal Antibodies to Botulinum Neurotoxin Type E.
    Bever CS; Scotcher M; Cheng LW; Hnasko RM; Stanker LH
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31337022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of botulinum neurotoxin serotype B at sub mouse LD(50) levels by a sandwich immunoassay and its application to toxin detection in milk.
    Scotcher MC; Cheng LW; Stanker LH
    PLoS One; 2010 Jun; 5(6):e11047. PubMed ID: 20548779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum neurotoxin detection and differentiation by mass spectrometry.
    Barr JR; Moura H; Boyer AE; Woolfitt AR; Kalb SR; Pavlopoulos A; McWilliams LG; Schmidt JG; Martinez RA; Ashley DL
    Emerg Infect Dis; 2005 Oct; 11(10):1578-83. PubMed ID: 16318699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposed BoNT/A and /B Peptide Substrates Cannot Detect Multiple Subtypes in the Endopep-MS Assay.
    Kalb SR; Baudys J; Kiernan K; Wang D; Becher F; Barr JR
    J Anal Toxicol; 2020 Mar; 44(2):173-179. PubMed ID: 31287544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies.
    Kalb SR; Santana WI; Geren IN; Garcia-Rodriguez C; Lou J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR
    BMC Biochem; 2011 Nov; 12():58. PubMed ID: 22085466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.